
GC64995
RIPGBM
Also known as N-[3-(benzylamino)-1,4-dioxonaphthalen-2-yl]-N-[(4-fluorophenyl)methyl]acetamide
RIPGBM is a selective inducer of apoptosis in glioblastoma multiforme (GBM) cancer stem cells (CSCs) with an EC50 of ≤500 nM
ChemicalCAS355406-76-7MW428.45FormulaC26H21FN2O3
- CAS number
- 355406-76-7
- Molecular weight
- 428.45
- Formula
- C26H21FN2O3
- Solubility
- DMSO : 33·33 mg/mL (77·79 mM; Need ultrasonic)
- InChIKey
- COATXBHZYVUJQP-UHFFFAOYSA-N
- Catalogue number
- GC64995
- Brand
- GLPBIO
Computed properties PubChem CID 3793001 · XLogP 4.3 · TPSA 66.5 Ų · H-bond donors 1
- XLogP
- 4.3
- TPSA
- 66.5 Ų
- H-bond donors
- 1
- H-bond acceptors
- 5
- Rotatable bonds
- 6
- Heavy atoms
- 32
SMILES CC(=O)N(CC1=CC=C(C=C1)F)C2=C(C(=O)C3=CC=CC=C3C2=O)NCC4=CC=CC=C4
Computed descriptors from PubChem (CID 3793001), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il